# Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy

> **NCT02733471** · PHASE4 · COMPLETED · sponsor: **Basque Health Service** · enrollment: 586 (actual)

## Conditions studied

- Tolerance

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02733471
- **Lead sponsor:** Basque Health Service
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-04
- **Final completion:** 2017-05
- **Target enrollment:** 586 (ACTUAL)
- **Last updated:** 2018-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733471, "Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02733471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*